Albert Bourla - Pfizer Insider

PFE -- Germany Stock  

EUR 30.98  0.55  1.74%

Group President - Vaccines, Oncology and Consumer Healthcare Business

Mr. Albert Bourla is re designated as Chief Operating Officer, Director of the company. He was Group President, Global Innovative Pharma Business from February 2016 until June 2016 and Group President, Vaccines, Oncology and Consumer Healthcare since January 2014. President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.
Age: 55  President Since 2018      
212-733-2323  http://www.pfizer.com

Albert Bourla Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 5.49 % which means that it generated profit of $5.49 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 32.48 % meaning that it generated $32.48 on every $100 dollars invested by stockholders.
The company has accumulated 43.67 B in total debt with debt to equity ratio (D/E) of 60.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pfizer has Current Ratio of 1.32 which is within standard range for the sector.

Similar Executives

Entity Summary

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug Manufacturers - Major classification in Germany and traded on Frankfurt Stock Exchange. It employs 90200 people.Pfizer (PFE) is traded on Frankfurt Stock Exchange in Germany. It is located in 235 East 42nd Street and employs 90,200 people.

Pfizer Leadership Team

John Young, President
Frank DAmelio, President
Douglas Lankler, President
Helen Hobbs, Director, Ph.D
Shantanu Narayen, Director
James Smith, Director
Dennis Ausiello, Director, Ph.D
Mikael Dolsten, President, Ph.D
Frances Fergusson, Director, Ph.D
Stephen Sanger, Director
Suzanne Johnson, Director
Alexander Mackenzie, President
Geno Germano, President
Laurie Olson, President
Sally Susman, President
Anthony Maddaluna, President
Freda LewisHall, President
Rady Johnson, President
Dan Littman, Director, Ph.D
Ian Read, Chairman
James Kilts, Director
Don Cornwell, Director
Charles Hill, President
Joseph Echevarria, Director
Albert Bourla, President
Kirsten LundJurgensen, President
Angela Hwang, President
Ronald Blaylock, Director
Kathrin Jansen, President, Ph.D

Stock Performance Indicators

Did you try this?

Run Equity Search Now
   

Equity Search

Search for activelly-traded equities including funds and ETFs from over 30 global markets
All  Next Launch Equity Search

Trending Equities

Currently Active Assets on Macroaxis
OZL   
Purchased over 100 shares of
over a week ago
Traded for 10.44
FBU   
Purchased over 300 shares of
over a week ago
Traded for 6.24
JBH   
Purchased over 70 shares of
over a week ago
Traded for 23.42
GNC   
Purchased over 200 shares of
over a week ago
Traded for 8.1
SBM   
Purchased over 400 shares of
over a week ago
Traded for 4.74
Additionally take a look at Your Equity Center. Please also try Portfolio Quick Import module to import or update all your transactions via one easy-to-use interface.